

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 4.77481788 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.77481788 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.40769214 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.24634438 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.24011833 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.24011833 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.17943163 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.17943163 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.17943163 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.17943163 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.17943163 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 4.17943163 |
| 13 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.17399550 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.05733153 |
| 15 | leukocyte aggregation (GO:0070486) | 3.91895844 |
| 16 | detection of other organism (GO:0098543) | 3.73916810 |
| 17 | membrane raft organization (GO:0031579) | 3.72402935 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.71108088 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.62900032 |
| 20 | negative regulation of phagocytosis (GO:0050765) | 3.54408777 |
| 21 | protein localization to endosome (GO:0036010) | 3.53110957 |
| 22 | detection of bacterium (GO:0016045) | 3.50554255 |
| 23 | cellular extravasation (GO:0045123) | 3.50368282 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.46250485 |
| 25 | detection of molecule of bacterial origin (GO:0032490) | 3.44454312 |
| 26 | positive regulation of lamellipodium assembly (GO:0010592) | 3.40651481 |
| 27 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.37521791 |
| 28 | detection of external biotic stimulus (GO:0098581) | 3.37221497 |
| 29 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.34438932 |
| 30 | positive thymic T cell selection (GO:0045059) | 3.32482247 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 3.32217578 |
| 32 | regulation of mast cell degranulation (GO:0043304) | 3.32114127 |
| 33 | negative thymic T cell selection (GO:0045060) | 3.26703391 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 3.25333087 |
| 35 | B cell receptor signaling pathway (GO:0050853) | 3.25110432 |
| 36 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.17160189 |
| 37 | cortical actin cytoskeleton organization (GO:0030866) | 3.13971484 |
| 38 | negative T cell selection (GO:0043383) | 3.13940384 |
| 39 | actin nucleation (GO:0045010) | 3.13276190 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.10609999 |
| 41 | tolerance induction (GO:0002507) | 3.06185449 |
| 42 | hepatocyte apoptotic process (GO:0097284) | 3.06180688 |
| 43 | germ cell migration (GO:0008354) | 3.05432377 |
| 44 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.03844305 |
| 45 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.02944823 |
| 46 | thymic T cell selection (GO:0045061) | 3.02671880 |
| 47 | neutrophil mediated immunity (GO:0002446) | 2.99741521 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.99726390 |
| 49 | leukocyte cell-cell adhesion (GO:0007159) | 2.98808513 |
| 50 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96167721 |
| 51 | response to host immune response (GO:0052572) | 2.96167721 |
| 52 | detection of biotic stimulus (GO:0009595) | 2.95370568 |
| 53 | B cell mediated immunity (GO:0019724) | 2.95090517 |
| 54 | positive regulation of lamellipodium organization (GO:1902745) | 2.93252374 |
| 55 | neutrophil activation (GO:0042119) | 2.92543210 |
| 56 | response to peptidoglycan (GO:0032494) | 2.92449223 |
| 57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.92050138 |
| 58 | response to host defenses (GO:0052200) | 2.91524299 |
| 59 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.91524299 |
| 60 | response to host (GO:0075136) | 2.91524299 |
| 61 | immunoglobulin mediated immune response (GO:0016064) | 2.89963849 |
| 62 | mannose metabolic process (GO:0006013) | 2.87537737 |
| 63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87060164 |
| 64 | response to laminar fluid shear stress (GO:0034616) | 2.85373365 |
| 65 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.84916349 |
| 66 | cell adhesion mediated by integrin (GO:0033627) | 2.81699790 |
| 67 | granulocyte activation (GO:0036230) | 2.80851806 |
| 68 | response to fungus (GO:0009620) | 2.80738575 |
| 69 | positive regulation of histone deacetylation (GO:0031065) | 2.79267340 |
| 70 | apoptotic cell clearance (GO:0043277) | 2.78602181 |
| 71 | positive regulation of interferon-alpha production (GO:0032727) | 2.78425121 |
| 72 | stress fiber assembly (GO:0043149) | 2.77587431 |
| 73 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.77169201 |
| 74 | respiratory burst (GO:0045730) | 2.76979295 |
| 75 | leukocyte degranulation (GO:0043299) | 2.76774293 |
| 76 | hypotonic response (GO:0006971) | 2.74875413 |
| 77 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.73909663 |
| 78 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.73909663 |
| 79 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.73909663 |
| 80 | dendritic cell migration (GO:0036336) | 2.72757057 |
| 81 | type I interferon signaling pathway (GO:0060337) | 2.72252646 |
| 82 | cellular response to type I interferon (GO:0071357) | 2.72252646 |
| 83 | regulation of interferon-alpha production (GO:0032647) | 2.72211409 |
| 84 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.72067561 |
| 85 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.70603909 |
| 86 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.70192726 |
| 87 | negative regulation of interleukin-17 production (GO:0032700) | 2.69986403 |
| 88 | cortical cytoskeleton organization (GO:0030865) | 2.69714317 |
| 89 | T cell migration (GO:0072678) | 2.69322524 |
| 90 | negative regulation of interleukin-12 production (GO:0032695) | 2.68675071 |
| 91 | T cell selection (GO:0045058) | 2.68419295 |
| 92 | regulation of mast cell activation (GO:0033003) | 2.67823221 |
| 93 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.67808334 |
| 94 | response to type I interferon (GO:0034340) | 2.67751348 |
| 95 | barbed-end actin filament capping (GO:0051016) | 2.66044066 |
| 96 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.65723760 |
| 97 | positive regulation of mast cell degranulation (GO:0043306) | 2.65723760 |
| 98 | regulation of B cell differentiation (GO:0045577) | 2.65520080 |
| 99 | myeloid cell activation involved in immune response (GO:0002275) | 2.65261514 |
| 100 | germinal center formation (GO:0002467) | 2.64503527 |
| 101 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.63218406 |
| 102 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.62561448 |
| 103 | negative regulation of T cell mediated immunity (GO:0002710) | 2.62553287 |
| 104 | positive regulation of leukocyte degranulation (GO:0043302) | 2.61851005 |
| 105 | NIK/NF-kappaB signaling (GO:0038061) | 2.61753679 |
| 106 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.60956839 |
| 107 | regulation of T cell tolerance induction (GO:0002664) | 2.60899326 |
| 108 | receptor catabolic process (GO:0032801) | 2.60885262 |
| 109 | dendritic cell chemotaxis (GO:0002407) | 2.59741947 |
| 110 | regulation of early endosome to late endosome transport (GO:2000641) | 2.59227774 |
| 111 | endodermal cell differentiation (GO:0035987) | 2.59193885 |
| 112 | regulation of protein heterodimerization activity (GO:0043497) | 2.56139825 |
| 113 | positive T cell selection (GO:0043368) | 2.55797435 |
| 114 | platelet aggregation (GO:0070527) | 2.55660402 |
| 115 | regulation of leukocyte degranulation (GO:0043300) | 2.55588124 |
| 116 | positive regulation of B cell differentiation (GO:0045579) | 2.55015019 |
| 117 | substrate-dependent cell migration (GO:0006929) | 2.53979245 |
| 118 | T cell costimulation (GO:0031295) | 2.52630281 |
| 119 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.52531521 |
| 120 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.51909282 |
| 121 | response to muramyl dipeptide (GO:0032495) | 2.50718305 |
| 122 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.50643917 |
| 123 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.50280578 |
| 124 | integrin-mediated signaling pathway (GO:0007229) | 2.50006864 |
| 125 | pinocytosis (GO:0006907) | 2.49267985 |
| 126 | myeloid leukocyte mediated immunity (GO:0002444) | 2.49210496 |
| 127 | regulation of tolerance induction (GO:0002643) | 2.48893720 |
| 128 | natural killer cell differentiation (GO:0001779) | 2.46432057 |
| 129 | defense response to fungus (GO:0050832) | 2.46360450 |
| 130 | lymphocyte costimulation (GO:0031294) | 2.46027659 |
| 131 | response to interleukin-15 (GO:0070672) | 2.44915337 |
| 132 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.44497886 |
| 133 | macrophage differentiation (GO:0030225) | 2.41839808 |
| 134 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.39671024 |
| 135 | positive regulation of macrophage differentiation (GO:0045651) | 2.38437330 |
| 136 | positive regulation of mast cell activation (GO:0033005) | 2.36912956 |
| 137 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.36749213 |
| 138 | positive regulation of tolerance induction (GO:0002645) | 2.36634128 |
| 139 | regulation of macrophage cytokine production (GO:0010935) | 2.35566208 |
| 140 | establishment of endothelial barrier (GO:0061028) | 2.35564554 |
| 141 | negative regulation of granulocyte differentiation (GO:0030853) | 2.35308999 |
| 142 | neutrophil chemotaxis (GO:0030593) | 2.35073500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.15868984 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.05772048 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.64637685 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.57686334 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.42673360 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.27354924 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.95143354 |
| 8 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.91070927 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.89402318 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.83661381 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76499480 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.75284699 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70329961 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.38123583 |
| 15 | * MAF_26560356_Chip-Seq_TH1_Human | 2.37659679 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.36907213 |
| 17 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.35347220 |
| 18 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.34394096 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.28376167 |
| 20 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.26104007 |
| 21 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.25250836 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.19590570 |
| 23 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.16839944 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.14045085 |
| 25 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.13869286 |
| 26 | * MYB_26560356_Chip-Seq_TH2_Human | 2.13553175 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 2.11874459 |
| 28 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.08080135 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.04517290 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.98807922 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.96426872 |
| 32 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91087970 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.87699138 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.87645381 |
| 35 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.85335410 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84427037 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.83456547 |
| 38 | * MYB_26560356_Chip-Seq_TH1_Human | 1.80163280 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.79746459 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78472073 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74521792 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.74209884 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.74131858 |
| 44 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73610122 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.72763397 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70149171 |
| 47 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.61797213 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.60359139 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.60047396 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.59966574 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58054316 |
| 52 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.56120151 |
| 53 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55488239 |
| 54 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.54631070 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53980024 |
| 56 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.52653850 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45523010 |
| 58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45011368 |
| 59 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44908643 |
| 60 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42917540 |
| 61 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.39776647 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38916933 |
| 63 | * MAF_26560356_Chip-Seq_TH2_Human | 1.37925368 |
| 64 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35484721 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35143037 |
| 66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.34607469 |
| 67 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.32838987 |
| 68 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.31098294 |
| 69 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30788356 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28912463 |
| 71 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26876304 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25468378 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24708843 |
| 74 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24109726 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23743757 |
| 76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21589042 |
| 77 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.21523303 |
| 78 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19492579 |
| 79 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19460929 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16561185 |
| 81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.16489280 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12781181 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11252049 |
| 84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09928723 |
| 85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09868850 |
| 86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09086164 |
| 87 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07253603 |
| 88 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.06817113 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06750963 |
| 90 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05601962 |
| 91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05080058 |
| 92 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.02895707 |
| 93 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02847685 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02444931 |
| 95 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.02338678 |
| 96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02293577 |
| 97 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02048827 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01073478 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00994387 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00323102 |
| 101 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99595754 |
| 102 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99386682 |
| 103 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98026302 |
| 104 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98022638 |
| 105 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98022638 |
| 106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97722567 |
| 107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97243874 |
| 108 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97066881 |
| 109 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96411810 |
| 110 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95413769 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95269624 |
| 112 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93918059 |
| 113 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.92493803 |
| 114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90977936 |
| 115 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.90976361 |
| 116 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.90390212 |
| 117 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90275352 |
| 118 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87996235 |
| 119 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.87657443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.87563880 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.57834388 |
| 3 | MP0003436_decreased_susceptibility_to | 3.23253594 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 2.59144523 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.53052630 |
| 6 | MP0003566_abnormal_cell_adhesion | 2.47726408 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.45456825 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.41074824 |
| 9 | MP0009278_abnormal_bone_marrow | 2.31689219 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.29080604 |
| 11 | MP0002419_abnormal_innate_immunity | 2.20155730 |
| 12 | MP0000685_abnormal_immune_system | 2.16870044 |
| 13 | MP0001800_abnormal_humoral_immune | 2.13976462 |
| 14 | MP0005076_abnormal_cell_differentiation | 2.12644308 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.08829839 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.05165498 |
| 17 | MP0001790_abnormal_immune_system | 2.05071141 |
| 18 | MP0005387_immune_system_phenotype | 2.05071141 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 2.03164977 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.02673550 |
| 21 | MP0005451_abnormal_body_composition | 1.98011424 |
| 22 | MP0006082_CNS_inflammation | 1.95852453 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 1.94273956 |
| 24 | MP0002420_abnormal_adaptive_immunity | 1.93923401 |
| 25 | MP0001819_abnormal_immune_cell | 1.93031771 |
| 26 | MP0005671_abnormal_response_to | 1.92343067 |
| 27 | MP0004510_myositis | 1.92123576 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.88327965 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.87292439 |
| 30 | MP0004947_skin_inflammation | 1.86495310 |
| 31 | MP0005025_abnormal_response_to | 1.86193464 |
| 32 | MP0002723_abnormal_immune_serum | 1.85787460 |
| 33 | MP0003448_altered_tumor_morphology | 1.82366932 |
| 34 | MP0005023_abnormal_wound_healing | 1.79377502 |
| 35 | MP0003091_abnormal_cell_migration | 1.77787727 |
| 36 | MP0000858_altered_metastatic_potential | 1.77099432 |
| 37 | MP0009785_altered_susceptibility_to | 1.76658094 |
| 38 | MP0010307_abnormal_tumor_latency | 1.69142692 |
| 39 | MP0002405_respiratory_system_inflammati | 1.67970761 |
| 40 | MP0002398_abnormal_bone_marrow | 1.66741817 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.61739303 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.61301103 |
| 43 | MP0002006_tumorigenesis | 1.58226916 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.57542969 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.55151378 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.54119893 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.54119893 |
| 48 | MP0000716_abnormal_immune_system | 1.52915521 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.49358920 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.47156448 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.43353020 |
| 52 | MP0003075_altered_response_to | 1.42606298 |
| 53 | MP0002933_joint_inflammation | 1.41717230 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.41565395 |
| 55 | MP0002722_abnormal_immune_system | 1.39618971 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.38739939 |
| 57 | MP0001542_abnormal_bone_strength | 1.33809725 |
| 58 | MP0001958_emphysema | 1.33553277 |
| 59 | MP0003279_aneurysm | 1.33104454 |
| 60 | MP0001853_heart_inflammation | 1.31438087 |
| 61 | MP0008004_abnormal_stomach_pH | 1.30753443 |
| 62 | MP0000343_altered_response_to | 1.30419958 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 1.26442173 |
| 64 | MP0002429_abnormal_blood_cell | 1.25865385 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 1.24496404 |
| 66 | MP0001873_stomach_inflammation | 1.23425734 |
| 67 | MP0006054_spinal_hemorrhage | 1.20310122 |
| 68 | MP0000604_amyloidosis | 1.19551472 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.17989817 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.16763489 |
| 71 | MP0003045_fibrosis | 1.16449354 |
| 72 | MP0003724_increased_susceptibility_to | 1.15184007 |
| 73 | MP0002396_abnormal_hematopoietic_system | 1.15143280 |
| 74 | MP0003183_abnormal_peptide_metabolism | 1.14756571 |
| 75 | MP0000703_abnormal_thymus_morphology | 1.13604757 |
| 76 | MP0005310_abnormal_salivary_gland | 1.12827228 |
| 77 | MP0005166_decreased_susceptibility_to | 1.12463588 |
| 78 | MP0003866_abnormal_defecation | 1.11554179 |
| 79 | MP0000490_abnormal_crypts_of | 1.09005517 |
| 80 | MP0001851_eye_inflammation | 1.08350850 |
| 81 | MP0003191_abnormal_cellular_cholesterol | 1.06747401 |
| 82 | MP0005164_abnormal_response_to | 1.05263221 |
| 83 | MP0009764_decreased_sensitivity_to | 1.03944647 |
| 84 | MP0009840_abnormal_foam_cell | 1.00263386 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.99639995 |
| 86 | MP0000733_abnormal_muscle_development | 0.99465122 |
| 87 | MP0001849_ear_inflammation | 0.98823693 |
| 88 | MP0005275_abnormal_skin_tensile | 0.95420866 |
| 89 | MP0002132_abnormal_respiratory_system | 0.94501241 |
| 90 | MP0005390_skeleton_phenotype | 0.93927527 |
| 91 | MP0004381_abnormal_hair_follicle | 0.93888551 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 0.91636750 |
| 93 | MP0003806_abnormal_nucleotide_metabolis | 0.91004886 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.90389194 |
| 95 | MP0008469_abnormal_protein_level | 0.89021418 |
| 96 | MP0009763_increased_sensitivity_to | 0.84681795 |
| 97 | MP0003828_pulmonary_edema | 0.81767527 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.81147539 |
| 99 | MP0005623_abnormal_meninges_morphology | 0.81025300 |
| 100 | MP0005257_abnormal_intraocular_pressure | 0.80902527 |
| 101 | MP0000249_abnormal_blood_vessel | 0.76610767 |
| 102 | MP0003795_abnormal_bone_structure | 0.74995956 |
| 103 | MP0002019_abnormal_tumor_incidence | 0.73264693 |
| 104 | MP0001915_intracranial_hemorrhage | 0.72106926 |
| 105 | MP0005165_increased_susceptibility_to | 0.70825470 |
| 106 | MP0005174_abnormal_tail_pigmentation | 0.70176647 |
| 107 | MP0001216_abnormal_epidermal_layer | 0.67932047 |
| 108 | MP0005621_abnormal_cell_physiology | 0.67709410 |
| 109 | MP0002060_abnormal_skin_morphology | 0.65908765 |
| 110 | MP0000767_abnormal_smooth_muscle | 0.65717155 |
| 111 | MP0001663_abnormal_digestive_system | 0.64878264 |
| 112 | MP0004883_abnormal_blood_vessel | 0.64785540 |
| 113 | MP0000477_abnormal_intestine_morphology | 0.63315543 |
| 114 | MP0008260_abnormal_autophagy | 0.61361528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.40956021 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.05434152 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 3.57161910 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 3.30785151 |
| 5 | Cerebral aneurysm (HP:0004944) | 3.29971732 |
| 6 | Cellulitis (HP:0100658) | 3.20368339 |
| 7 | Petechiae (HP:0000967) | 2.97071750 |
| 8 | Increased density of long bones (HP:0006392) | 2.96457363 |
| 9 | Abnormality of macrophages (HP:0004311) | 2.92548783 |
| 10 | Recurrent fungal infections (HP:0002841) | 2.91264547 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.88966052 |
| 12 | Dysostosis multiplex (HP:0000943) | 2.84599755 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 2.77051516 |
| 14 | Hematochezia (HP:0002573) | 2.76794292 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.75587216 |
| 16 | Obstructive lung disease (HP:0006536) | 2.72790809 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72790809 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 2.71572664 |
| 19 | Optic neuritis (HP:0100653) | 2.71572664 |
| 20 | Abnormal platelet volume (HP:0011876) | 2.68253766 |
| 21 | Epistaxis (HP:0000421) | 2.66329699 |
| 22 | Prolonged bleeding time (HP:0003010) | 2.65145992 |
| 23 | Gingival bleeding (HP:0000225) | 2.63093542 |
| 24 | Dilatation of the ascending aorta (HP:0005111) | 2.62318479 |
| 25 | Myositis (HP:0100614) | 2.60345010 |
| 26 | Protrusio acetabuli (HP:0003179) | 2.59834663 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 2.58065511 |
| 28 | Urticaria (HP:0001025) | 2.57469280 |
| 29 | Recurrent viral infections (HP:0004429) | 2.54824129 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 2.54791772 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 2.54079217 |
| 32 | Hepatosplenomegaly (HP:0001433) | 2.53935581 |
| 33 | Aortic aneurysm (HP:0004942) | 2.51516510 |
| 34 | Verrucae (HP:0200043) | 2.51455247 |
| 35 | Papilloma (HP:0012740) | 2.51455247 |
| 36 | Osteolytic defects of the hand bones (HP:0009699) | 2.51435721 |
| 37 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.51435721 |
| 38 | Stomatitis (HP:0010280) | 2.46881307 |
| 39 | Increased mean platelet volume (HP:0011877) | 2.46375303 |
| 40 | Premature rupture of membranes (HP:0001788) | 2.45615113 |
| 41 | Peritonitis (HP:0002586) | 2.44025905 |
| 42 | Myocardial infarction (HP:0001658) | 2.43907903 |
| 43 | Amyloidosis (HP:0011034) | 2.43810002 |
| 44 | Ankle contracture (HP:0006466) | 2.42865490 |
| 45 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.39196600 |
| 46 | Mucopolysacchariduria (HP:0008155) | 2.39196600 |
| 47 | Aortic dissection (HP:0002647) | 2.38904343 |
| 48 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.36737541 |
| 49 | Disinhibition (HP:0000734) | 2.35941106 |
| 50 | Mitral valve prolapse (HP:0001634) | 2.34627652 |
| 51 | Chronic otitis media (HP:0000389) | 2.32995270 |
| 52 | Leukocytosis (HP:0001974) | 2.31109120 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.29440758 |
| 54 | Meningitis (HP:0001287) | 2.26284869 |
| 55 | Purpura (HP:0000979) | 2.25661119 |
| 56 | Encephalitis (HP:0002383) | 2.25462886 |
| 57 | Cervical subluxation (HP:0003308) | 2.24434100 |
| 58 | Gingivitis (HP:0000230) | 2.23724195 |
| 59 | Recurrent skin infections (HP:0001581) | 2.23562894 |
| 60 | Short nail (HP:0001799) | 2.22738803 |
| 61 | Autoimmune thrombocytopenia (HP:0001973) | 2.21301121 |
| 62 | Increased IgE level (HP:0003212) | 2.18792332 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.18641601 |
| 64 | Amaurosis fugax (HP:0100576) | 2.17585499 |
| 65 | Pustule (HP:0200039) | 2.17415921 |
| 66 | Granulocytopenia (HP:0001913) | 2.17204032 |
| 67 | Shallow orbits (HP:0000586) | 2.14868514 |
| 68 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.14149871 |
| 69 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.14149871 |
| 70 | Abnormality of glycolipid metabolism (HP:0010969) | 2.14149871 |
| 71 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.13975664 |
| 72 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.13975664 |
| 73 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.13975664 |
| 74 | Genu recurvatum (HP:0002816) | 2.13248546 |
| 75 | Keratoconjunctivitis sicca (HP:0001097) | 2.12349373 |
| 76 | Abnormality of T cells (HP:0002843) | 2.11954293 |
| 77 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.10899485 |
| 78 | Papilledema (HP:0001085) | 2.09930426 |
| 79 | Inflammation of the large intestine (HP:0002037) | 2.09296335 |
| 80 | Hemoptysis (HP:0002105) | 2.09293003 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.07823390 |
| 82 | Striae distensae (HP:0001065) | 2.06723632 |
| 83 | Persistence of primary teeth (HP:0006335) | 2.06569469 |
| 84 | Nasal polyposis (HP:0100582) | 2.05525834 |
| 85 | Thick nail (HP:0001805) | 2.05050379 |
| 86 | Arterial thrombosis (HP:0004420) | 2.04863761 |
| 87 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.03470300 |
| 88 | Osteomyelitis (HP:0002754) | 2.03186371 |
| 89 | Upper motor neuron abnormality (HP:0002127) | 2.03128124 |
| 90 | Orchitis (HP:0100796) | 2.02659774 |
| 91 | Skin ulcer (HP:0200042) | 2.01651488 |
| 92 | Entropion (HP:0000621) | 2.01055651 |
| 93 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.00025614 |
| 94 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99951291 |
| 95 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99951291 |
| 96 | Hypergammaglobulinemia (HP:0010702) | 1.99802009 |
| 97 | Premature loss of primary teeth (HP:0006323) | 1.99748365 |
| 98 | Diminished motivation (HP:0000745) | 1.99520363 |
| 99 | Periodontitis (HP:0000704) | 1.99314120 |
| 100 | Vertebral compression fractures (HP:0002953) | 1.98986883 |
| 101 | Ulnar bowing (HP:0003031) | 1.97479810 |
| 102 | Systemic lupus erythematosus (HP:0002725) | 1.97186948 |
| 103 | Loss of speech (HP:0002371) | 1.96655202 |
| 104 | Increased IgM level (HP:0003496) | 1.96392886 |
| 105 | Abnormality of the nasal mucosa (HP:0000433) | 1.95976932 |
| 106 | Thrombocytosis (HP:0001894) | 1.95657071 |
| 107 | Colitis (HP:0002583) | 1.94216941 |
| 108 | Apathy (HP:0000741) | 1.93970643 |
| 109 | Abnormal platelet function (HP:0011869) | 1.92904004 |
| 110 | Impaired platelet aggregation (HP:0003540) | 1.92904004 |
| 111 | Fatigue (HP:0012378) | 1.91201137 |
| 112 | Glomerulopathy (HP:0100820) | 1.90316766 |
| 113 | Abnormality of oral frenula (HP:0000190) | 1.89195872 |
| 114 | Polycythemia (HP:0001901) | 1.88787006 |
| 115 | Chest pain (HP:0100749) | 1.88445999 |
| 116 | Upper limb amyotrophy (HP:0009129) | 1.88333839 |
| 117 | Distal upper limb amyotrophy (HP:0007149) | 1.88333839 |
| 118 | Hyperacusis (HP:0010780) | 1.86995325 |
| 119 | Abnormality of T cell physiology (HP:0011840) | 1.86165536 |
| 120 | Recurrent bronchitis (HP:0002837) | 1.86151782 |
| 121 | Spondylolisthesis (HP:0003302) | 1.85785394 |
| 122 | Keratoconjunctivitis (HP:0001096) | 1.85698891 |
| 123 | Abnormality of the peritoneum (HP:0002585) | 1.85674403 |
| 124 | Thoracic kyphosis (HP:0002942) | 1.85511577 |
| 125 | Absent frontal sinuses (HP:0002688) | 1.84747999 |
| 126 | Axonal loss (HP:0003447) | 1.84656166 |
| 127 | Subacute progressive viral hepatitis (HP:0006572) | 1.84599562 |
| 128 | IgM deficiency (HP:0002850) | 1.83186948 |
| 129 | T lymphocytopenia (HP:0005403) | 1.82831287 |
| 130 | Autoimmune hemolytic anemia (HP:0001890) | 1.82280201 |
| 131 | Eosinophilia (HP:0001880) | 1.81692270 |
| 132 | Lymphopenia (HP:0001888) | 1.79865038 |
| 133 | Increased CSF protein (HP:0002922) | 1.78314329 |
| 134 | Arterial tortuosity (HP:0005116) | 1.77838487 |
| 135 | Vasculitis (HP:0002633) | 1.77686392 |
| 136 | Glucose intolerance (HP:0000833) | 1.77522858 |
| 137 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.76937568 |
| 138 | Abnormality of T cell number (HP:0011839) | 1.76292843 |
| 139 | Arthralgia (HP:0002829) | 1.75551746 |
| 140 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.75495614 |
| 141 | Acrocyanosis (HP:0001063) | 1.75092528 |
| 142 | Frequent falls (HP:0002359) | 1.74830857 |
| 143 | Atrophic scars (HP:0001075) | 1.74298598 |
| 144 | Bicuspid aortic valve (HP:0001647) | 1.74135653 |
| 145 | Rough bone trabeculation (HP:0100670) | 1.74008322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.85582615 |
| 2 | MAP4K1 | 3.09620418 |
| 3 | PKN2 | 2.95014358 |
| 4 | STK10 | 2.43758871 |
| 5 | EEF2K | 2.42870711 |
| 6 | ERN1 | 2.37177416 |
| 7 | GRK6 | 2.35513658 |
| 8 | PRPF4B | 2.29553729 |
| 9 | TESK2 | 2.28054308 |
| 10 | LRRK2 | 2.19937079 |
| 11 | TTN | 2.12028259 |
| 12 | MAP3K10 | 2.10771376 |
| 13 | FES | 1.99438271 |
| 14 | EPHB1 | 1.87806278 |
| 15 | TESK1 | 1.79793661 |
| 16 | EIF2AK3 | 1.77496016 |
| 17 | RIPK4 | 1.77134364 |
| 18 | SIK3 | 1.63880913 |
| 19 | TYK2 | 1.59890455 |
| 20 | CSK | 1.55665080 |
| 21 | JAK1 | 1.55109229 |
| 22 | KIT | 1.53748975 |
| 23 | TGFBR2 | 1.53453920 |
| 24 | RIPK1 | 1.52800054 |
| 25 | HCK | 1.52703071 |
| 26 | PTK6 | 1.52515685 |
| 27 | ITK | 1.50586956 |
| 28 | BLK | 1.50058106 |
| 29 | TRPM7 | 1.49434997 |
| 30 | KSR2 | 1.46096282 |
| 31 | ALK | 1.44304993 |
| 32 | SCYL2 | 1.44246600 |
| 33 | ZAP70 | 1.43680477 |
| 34 | IRAK3 | 1.32732017 |
| 35 | TBK1 | 1.31404335 |
| 36 | PAK4 | 1.30889269 |
| 37 | JAK3 | 1.29467447 |
| 38 | CDK12 | 1.26204719 |
| 39 | BTK | 1.25853877 |
| 40 | BMX | 1.20452483 |
| 41 | CSF1R | 1.20381369 |
| 42 | TAOK1 | 1.18855157 |
| 43 | FGFR3 | 1.18134355 |
| 44 | NME2 | 1.15600570 |
| 45 | PIK3CG | 1.11001112 |
| 46 | MAP2K3 | 1.10633707 |
| 47 | YES1 | 1.10284165 |
| 48 | FGFR4 | 1.08592294 |
| 49 | CLK1 | 1.07338613 |
| 50 | SYK | 1.06462601 |
| 51 | CAMKK1 | 1.05918877 |
| 52 | BMPR2 | 1.01977751 |
| 53 | TXK | 0.99192865 |
| 54 | FGR | 0.98926981 |
| 55 | SMG1 | 0.98054983 |
| 56 | CDK6 | 0.96256232 |
| 57 | JAK2 | 0.95610646 |
| 58 | TAOK2 | 0.92827244 |
| 59 | PRKCH | 0.91451703 |
| 60 | SIK2 | 0.90559637 |
| 61 | PDGFRA | 0.89264174 |
| 62 | LCK | 0.88854883 |
| 63 | IRAK4 | 0.88299611 |
| 64 | TAOK3 | 0.88031115 |
| 65 | MAP3K9 | 0.86566397 |
| 66 | RPS6KA4 | 0.85918065 |
| 67 | MAP3K8 | 0.84713019 |
| 68 | PIM1 | 0.84670576 |
| 69 | TEC | 0.84176594 |
| 70 | DMPK | 0.83732738 |
| 71 | NLK | 0.75971351 |
| 72 | PTK2 | 0.75651043 |
| 73 | MAP3K2 | 0.74207811 |
| 74 | MAP3K12 | 0.72288762 |
| 75 | STK24 | 0.71539879 |
| 76 | RET | 0.71363464 |
| 77 | CAMK1D | 0.71149410 |
| 78 | MAP3K6 | 0.69784190 |
| 79 | IKBKE | 0.69341692 |
| 80 | MYLK | 0.67701751 |
| 81 | MAP3K5 | 0.64009387 |
| 82 | MAP3K13 | 0.61470251 |
| 83 | MARK3 | 0.60799159 |
| 84 | MAP3K1 | 0.59982528 |
| 85 | MAP3K11 | 0.59604783 |
| 86 | PAK2 | 0.58844985 |
| 87 | MAPK7 | 0.58616220 |
| 88 | LYN | 0.57851745 |
| 89 | LIMK1 | 0.57591767 |
| 90 | PRKG2 | 0.56389047 |
| 91 | SGK3 | 0.56284836 |
| 92 | MAPKAPK2 | 0.56263057 |
| 93 | CAMKK2 | 0.56234061 |
| 94 | TNK2 | 0.55832676 |
| 95 | PDGFRB | 0.55584471 |
| 96 | MAP3K3 | 0.55361665 |
| 97 | MAPK12 | 0.54374124 |
| 98 | CDK4 | 0.53311826 |
| 99 | NEK2 | 0.53066912 |
| 100 | FYN | 0.52398864 |
| 101 | EGFR | 0.51049201 |
| 102 | CDC42BPA | 0.50679025 |
| 103 | PDK1 | 0.50567308 |
| 104 | NEK9 | 0.48933731 |
| 105 | CAMK1G | 0.48269882 |
| 106 | MAP3K14 | 0.46285648 |
| 107 | DYRK1B | 0.46280081 |
| 108 | PTK2B | 0.43383765 |
| 109 | IKBKB | 0.43320513 |
| 110 | KSR1 | 0.43125613 |
| 111 | ILK | 0.43039199 |
| 112 | PRKD2 | 0.43028813 |
| 113 | RPS6KA2 | 0.42696296 |
| 114 | ARAF | 0.42291529 |
| 115 | FRK | 0.41751782 |
| 116 | DDR2 | 0.40392957 |
| 117 | MOS | 0.39716917 |
| 118 | PRKCQ | 0.39437975 |
| 119 | MATK | 0.39409831 |
| 120 | MARK2 | 0.39166046 |
| 121 | SRC | 0.38259709 |
| 122 | PAK1 | 0.38238754 |
| 123 | ABL1 | 0.38208285 |
| 124 | GRK7 | 0.38013858 |
| 125 | KDR | 0.37144913 |
| 126 | PDPK1 | 0.36160181 |
| 127 | RAF1 | 0.35873167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.38116824 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.15018061 |
| 3 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.12631845 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.09176719 |
| 5 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.90710905 |
| 6 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.90650530 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.78071432 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.74519013 |
| 9 | Shigellosis_Homo sapiens_hsa05131 | 1.67089138 |
| 10 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.65955842 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.64538634 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.58075793 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.58047551 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.55291219 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54689006 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.46771560 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46633203 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.45281238 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44926622 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.44513180 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43529502 |
| 22 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.43509861 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.40930872 |
| 24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.38727117 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.37286317 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.36918265 |
| 27 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.33839790 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.32998623 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31192352 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.31177619 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31175904 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.31168326 |
| 33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.30933299 |
| 34 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.30070154 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.25005542 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.24844157 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24641318 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.23943858 |
| 39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.22760061 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.22310162 |
| 41 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.22285576 |
| 42 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.22044041 |
| 43 | Amoebiasis_Homo sapiens_hsa05146 | 1.18289715 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.16269348 |
| 45 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.15413191 |
| 46 | Focal adhesion_Homo sapiens_hsa04510 | 1.14351405 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12715824 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12137860 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09578361 |
| 50 | Endocytosis_Homo sapiens_hsa04144 | 1.08828382 |
| 51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.08443280 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.08063841 |
| 53 | Colorectal cancer_Homo sapiens_hsa05210 | 1.06489542 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.04660881 |
| 55 | Malaria_Homo sapiens_hsa05144 | 1.03939091 |
| 56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.03281612 |
| 57 | Adherens junction_Homo sapiens_hsa04520 | 1.02083760 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.01232736 |
| 59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96140620 |
| 60 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95938080 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 0.94943815 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 0.93636335 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92562368 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91926919 |
| 65 | Bladder cancer_Homo sapiens_hsa05219 | 0.89711938 |
| 66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.88550147 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.85170597 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84506781 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80307979 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79497721 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79058319 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78979978 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76157228 |
| 74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76024344 |
| 75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75023484 |
| 76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74693499 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73581907 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73478360 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73463429 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73129804 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72502626 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72327243 |
| 83 | Prostate cancer_Homo sapiens_hsa05215 | 0.71876365 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70951157 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70606012 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69056401 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.68105248 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66968955 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66878746 |
| 90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65519633 |
| 91 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63960408 |
| 92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62888773 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62246869 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61992536 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60737544 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60540638 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.60025478 |
| 98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59627954 |
| 99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.59210600 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59007915 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58154422 |
| 102 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57553759 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57144916 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56871531 |
| 105 | Allograft rejection_Homo sapiens_hsa05330 | 0.54935481 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52946344 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52599395 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.51478233 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50808334 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50765476 |
| 111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50528093 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49612137 |
| 113 | Asthma_Homo sapiens_hsa05310 | 0.48904007 |
| 114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48649782 |
| 115 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47510993 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47149272 |
| 117 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.45349577 |
| 118 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.39629293 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35341867 |

